在肠易激综合征伴腹泻患者的2期和3期研究中，艾卢沙多林显示缺乏滥用潜力

{"title":"在肠易激综合征伴腹泻患者的2期和3期研究中，艾卢沙多林显示缺乏滥用潜力","authors":"R. Fant, J. Henningfield, B. Cash, L. S. Dove, P. Covington","doi":"10.1016/j.cgh.2017.01.026","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10409,"journal":{"name":"Clinical Gastroenterology & Hepatology","volume":"14 1","pages":"1021–1029.e6"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":"{\"title\":\"Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea\",\"authors\":\"R. Fant, J. Henningfield, B. Cash, L. S. Dove, P. Covington\",\"doi\":\"10.1016/j.cgh.2017.01.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10409,\"journal\":{\"name\":\"Clinical Gastroenterology & Hepatology\",\"volume\":\"14 1\",\"pages\":\"1021–1029.e6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Gastroenterology & Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cgh.2017.01.026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Gastroenterology & Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.cgh.2017.01.026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}